Response: Reassessing the Use of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC

Liver International 2026

View at publisher

Authors: J -H Kim, Thomas C. C. Yau, Hong Jae Chon

DOI: 10.1111/liv.70554

Cited by: 0

References: 7

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies

References 7